Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESOC 2023 | Predicting outcomes after cerebral venous thrombosis

Diana Aguiar de Sousa, MD, PhD, University of Lisbon, Santa Maria Hospital, Lisbon, Portugal, discusses predicting outcomes and treatment responsiveness after cerebral venous thrombosis (CVT). Currently, there are scoring systems and prognostic factors which have emerged from cohort studies of patients with CVT. However, the disease is unpredictable, especially in the acute phase. It is difficult to predict which patients will have worse long-term outcomes and are likely to have an unfavourable course during the acute phase. Further research should be undertaken to uncover predictive markers for these patients, as these groups are more likely to benefit from more aggressive intervention during the acute phase. This interview took place during the European Stroke Organisation Conference (ESOC) in Munich, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Dr Aguiar de Sousa reported personal fees for AstraZeneca and Organon advisory board participation, travel support from Boehringer Ingelheim, DSMB participation for the SECRET trial (University of British Columbia), and speaking fees from Bayer and Bial.